[1]赵燕*,薛萍萍,姜宙,等.睾丸酮用于卵巢低反应患者辅助生殖治疗的 荟萃分析[J].中国计划生育和妇产科,2019,(1):34-40.
　ZHAO Yan*,XUE Ping-ping,JIANG Zhou,et al.Testosterone pretreatment in poor responders undergoing ART: a systematic meta-analysis[J].Chinese Journal of Family Planning & Gynecotokology,2019,(1):34-40.
点击复制

睾丸酮用于卵巢低反应患者辅助生殖治疗的 荟萃分析
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2019年1期
页码:
34-40
栏目:
论著与临床
出版日期:
2019-01-25

文章信息/Info

Title:
Testosterone pretreatment in poor responders undergoing ART: a systematic meta-analysis
作者:
赵燕*; 薛萍萍; 姜宙; 周易; 邹淑花
青岛市妇女儿童医院生殖中心
Author(s):
ZHAO Yan*; XUE Ping-ping; JIANG Zhou; ZHOU Yi; ZOU Shu-Hua
Reproductive Center,Qingdao Women and Children’s Hospital,Qingdao Shandong 266000,P.R.China
关键词:
卵巢低反应; 体外受精; 卵母细胞胞浆内单精子显微注射术; 睾丸酮; Meta分析
Keywords:
poor ovarian response; IVF; ICSI; testosterone; meta-analysis
分类号:
R 5886
摘要:
目的系统评价睾丸酮用于卵巢低反应（poor ovarian response，POR）患者辅助生殖（assisted reproductive therapy, ART）治疗后，对妊娠结局的影响。方法计算机检索PubMed数据库、EMBASE数据库、Cochrane图书馆、中国知网（CNKI）数据库、中国生物医学文献数据库（CBM）和万方医学数据库中发表于2006年1月至2018年1月前的原创性研究论文；收集采取睾丸酮治疗措施的 POR 型患者，执行 ART 后的随机对照实验（randomized co
Abstract:
ObjectiveTo evaluate testosterone pretreatment on the pregnancy outcomes in poor ovarian response(POR) patients undergoing assisted reproductive therapy(ART).MethodsSearch the original research paper published on the PubMed, EMBASE,Cochrane library,CNKI,C

参考文献/References:

［1］GARCIA-VELASCO J A, MORENO L, PACHECO A, et al. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study ［J］. Fertility and Sterility, 2005, 84 (1): 82-87. ［2］TONER J P. Progress we can be proud of: U.S. trends in assisted reproduction over the first 20 years ［J］. Fertility and Sterility, 2002, 78 (5): 943-950. ［3］FERRARETTI A P, LA MARCA A, FAUSER B C, et al. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria ［J］. Human Reproduction (Oxford, England), 2011, 26 (7): 1616-1624. ［4］FASOULIOTIS S J, SIMON A, LAUFER N. Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet ［J］. Journal of Assisted Reproduction and Genetics, 2000, 17 (7): 357-373. ［5］KYROU D, KOLIBIANAKIS E M, VENETIS C A, et al. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis ［J］. Fertility and Sterility, 2009, 91 (3): 749-766. ［6］BEN-RAFAEL Z, BIDER D, DAN U, et al. Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG ［J］. Journal of in Vitro Fertilization and Embryo Transfer : IVF, 1991, 8 (1): 33-36. ［7］WEIL S J, VENDOLA K, ZHOU J, et al. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations ［J］. The Journal of Clinical Endocrinology and Metabolism, 1998, 83 (7): 2479-2485. ［8］WALTERS K A. Role of androgens in normal and pathological ovarian function ［J］. Reproduction (Cambridge, England), 2015, 149 (4): R 193-R 218. ［9］SUNKARA S K, PUNDIR J, KHALAF Y. Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders:A meta-analysis ［J］. Reproductive BioMedicine Online, 2011, 22 (6): 545-555. ［10］BARAD D, BRILL H, GLEICHER N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function ［J］. Journal of Assisted Reproduction and Genetics, 2007, 24 (12): 629-634. ［11］BOSDOU J K, VENETIS C A, DAFOPOULOS K, et al. Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial ［J］. Human Reproduction (Oxford, England), 2016, 31 (5): 977-985. ［12］DOAN H T, QUAN L H, NGUYEN T T. The effectiveness of transdermal testosterone gel 1 % (androgel) for poor responders undergoing in vitro fertilization ［J］. Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology, 2017, 33 (12): 977-979. ［13］FBREGUES F, PEARRUBIA J, CREUS M, et al. Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial ［J］. Human Reproduction (Oxford, England), 2009, 24 (2): 349-359. ［14］KIM C H, AHN J W, MOON J W, et al. Ovarian features after 2 weeks, 3 weeks and 4 weeks transdermal testosterone gel treatment and their associated effect on IVF outcomes in poor responders ［J］. Development & reproduction, 2014, 18 (3): 145-152. ［15］KIM C H, HOWLES C M, LEE H A. The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders ［J］. Fertility and Sterility, 2011, 95 (2): 679-683. ［16］MASSIN N, CEDRIN-DURNERIN I, COUSSIEU C, et al. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique——a prospective, randomized, double-blind study ［J］. Human Reproduction (Oxford, England), 2006, 21(5): 1204-1211. ［17］GORGY A, NAUMANN N, BATES S, et al. Assisted conception following poor ovarian response to gonadotrophin stimulation ［J］. British Journal of Obstetrics and Gynaecology, 1997, 104 (12): 1420-1421. ［18］BARBIERI R L, SLUSS P M, POWERS R D, et al. Association of body mass index, age, and cigarette smoking with serum testosterone levels in cycling women undergoing in vitro fertilization ［J］. Fertility and Sterility, 2005, 83 (2): 302-308. ［19］FRATTARELLI J L, PETERSON E H. Effect of androgen levels on in vitro fertilization cycles ［J］. Fertility and Sterility, 2004, 81 (6): 1713-1714.

相似文献/References:

[1]方伟芬,檀大羡.胚胎培养箱换水间隔时间对IVF妊娠结局的影响[J].中国计划生育和妇产科,2009,(06):0.
　FANG Wei-fen,TAN Da-xian Population and family planning research center of Guangxi autonomous region,Nanning Guangxi 00,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(1):0.
[2]柳雪琴,乃东红.体外受精中卵巢反应不良的预测及处理[J].中国计划生育和妇产科,2009,(06):0.
[3]黄卡立,公方强,檀大羡,等.应用微刺激联合拮抗剂方案对76例卵巢低反应者进行体外受精-胚胎移植的临床研究[J].中国计划生育和妇产科,2010,(01):0.
　HUANG Ka-li,GONG Fang-qiang,TAN Da-xianResearch centre of population and family planning of Guangxi Zhuang Autonomous Region,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(1):0.
[4]檀大羡,牛向丽,吕福通,等.精子形态学、精子-透明质结合试验与体外受精率的相关性研究[J].中国计划生育和妇产科,2010,(02):0.
　TAN Da-xian,NIU Xiang-li,LV Fu-tong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(1):0.
[5]方伟芬,张海英.补救卵胞浆内单精子显微注射的应用进展[J].中国计划生育和妇产科,2010,(03):0.
[6]秦文松,刘英,段金良,等.体外受精-胚胎移植中受精失败的原因及补救措施[J].中国计划生育和妇产科,2011,(04):0.
　QIN Wen-song,LIU Ying,DUAN Jin-liangReproduction Center,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(1):0.
[7]曾玖芝,龚衍,梁梅玉,等.精子DNA损伤对常规体外受精-胚胎移植结局的影响[J].中国计划生育和妇产科,2015,(05):0.
　ZENG Jiu-zhi,GONG Yan,LIANG Mei-yu,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(1):0.
[8]刘芳,陈秀娟,赵杰,等.脱氢表雄酮联合微刺激方案在卵巢低反应体外受精-胚胎移植中的治疗效果[J].中国计划生育和妇产科,2016,(03):0.
　LIU Fang,CHEN Xiu-juan,ZHAO Jie,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(1):0.
[9]刘明慧,李媛.体外受精/单精子卵母细胞内注射治疗周期中高龄患者受精方式选择的研究进展[J].中国计划生育和妇产科,2016,(11):0.
[10]叶虹.高龄女性体外受精助孕的促排卵策略[J].中国计划生育和妇产科,2016,(12):1.

更新日期/Last Update: 2019-01-25